Global Biological Drug CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Biological Drug CDMO market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biological drug CDMO (Contract Development and Manufacturing Organization) is a company that specializes in the development and manufacturing of biological drugs. Biological drugs are complex molecules that are produced from living cells, and they include a wide range of products such as vaccines, monoclonal antibodies, and cell therapies.
This report is a detailed and comprehensive analysis for global Biological Drug CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biological Drug CDMO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biological Drug CDMO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biological Drug CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biological Drug CDMO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biological Drug CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biological Drug CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Samsung Biologics, Lonza, Boehringer Ingelheim, Catalent and BioCentriq, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biological Drug CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Biological Drug CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biological Drug CDMO, with revenue, gross margin and global market share of Biological Drug CDMO from 2018 to 2023.
Chapter 3, the Biological Drug CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biological Drug CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biological Drug CDMO.
Chapter 13, to describe Biological Drug CDMO research findings and conclusion.
Biological drug CDMO (Contract Development and Manufacturing Organization) is a company that specializes in the development and manufacturing of biological drugs. Biological drugs are complex molecules that are produced from living cells, and they include a wide range of products such as vaccines, monoclonal antibodies, and cell therapies.
This report is a detailed and comprehensive analysis for global Biological Drug CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biological Drug CDMO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biological Drug CDMO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biological Drug CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biological Drug CDMO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biological Drug CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biological Drug CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Samsung Biologics, Lonza, Boehringer Ingelheim, Catalent and BioCentriq, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biological Drug CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Innovative Drug
- Listed Patent Drugs
- Biosimilar
- Pharmaceutical Company
- Biotechnology Company
- Samsung Biologics
- Lonza
- Boehringer Ingelheim
- Catalent
- BioCentriq
- FUJIFILM Diosynth Biotechnologies
- Thermo Fisher Scientific
- Recipharm
- Delpharm
- Aenova
- Siegfried
- WuXi Biologics
- Obio Technology
- Hepalink
- Pharmaron
- ChemPartner
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Biological Drug CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biological Drug CDMO, with revenue, gross margin and global market share of Biological Drug CDMO from 2018 to 2023.
Chapter 3, the Biological Drug CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biological Drug CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biological Drug CDMO.
Chapter 13, to describe Biological Drug CDMO research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biological Drug CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biological Drug CDMO by Type
1.3.1 Overview: Global Biological Drug CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biological Drug CDMO Consumption Value Market Share by Type in 2022
1.3.3 Innovative Drug
1.3.4 Listed Patent Drugs
1.3.5 Biosimilar
1.4 Global Biological Drug CDMO Market by Application
1.4.1 Overview: Global Biological Drug CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.5 Global Biological Drug CDMO Market Size & Forecast
1.6 Global Biological Drug CDMO Market Size and Forecast by Region
1.6.1 Global Biological Drug CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biological Drug CDMO Market Size by Region, (2018-2029)
1.6.3 North America Biological Drug CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Biological Drug CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biological Drug CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Biological Drug CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biological Drug CDMO Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Samsung Biologics
2.1.1 Samsung Biologics Details
2.1.2 Samsung Biologics Major Business
2.1.3 Samsung Biologics Biological Drug CDMO Product and Solutions
2.1.4 Samsung Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Samsung Biologics Recent Developments and Future Plans
2.2 Lonza
2.2.1 Lonza Details
2.2.2 Lonza Major Business
2.2.3 Lonza Biological Drug CDMO Product and Solutions
2.2.4 Lonza Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Lonza Recent Developments and Future Plans
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Biological Drug CDMO Product and Solutions
2.3.4 Boehringer Ingelheim Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
2.4 Catalent
2.4.1 Catalent Details
2.4.2 Catalent Major Business
2.4.3 Catalent Biological Drug CDMO Product and Solutions
2.4.4 Catalent Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Catalent Recent Developments and Future Plans
2.5 BioCentriq
2.5.1 BioCentriq Details
2.5.2 BioCentriq Major Business
2.5.3 BioCentriq Biological Drug CDMO Product and Solutions
2.5.4 BioCentriq Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BioCentriq Recent Developments and Future Plans
2.6 FUJIFILM Diosynth Biotechnologies
2.6.1 FUJIFILM Diosynth Biotechnologies Details
2.6.2 FUJIFILM Diosynth Biotechnologies Major Business
2.6.3 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product and Solutions
2.6.4 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific Biological Drug CDMO Product and Solutions
2.7.4 Thermo Fisher Scientific Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.8 Recipharm
2.8.1 Recipharm Details
2.8.2 Recipharm Major Business
2.8.3 Recipharm Biological Drug CDMO Product and Solutions
2.8.4 Recipharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Recipharm Recent Developments and Future Plans
2.9 Delpharm
2.9.1 Delpharm Details
2.9.2 Delpharm Major Business
2.9.3 Delpharm Biological Drug CDMO Product and Solutions
2.9.4 Delpharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Delpharm Recent Developments and Future Plans
2.10 Aenova
2.10.1 Aenova Details
2.10.2 Aenova Major Business
2.10.3 Aenova Biological Drug CDMO Product and Solutions
2.10.4 Aenova Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Aenova Recent Developments and Future Plans
2.11 Siegfried
2.11.1 Siegfried Details
2.11.2 Siegfried Major Business
2.11.3 Siegfried Biological Drug CDMO Product and Solutions
2.11.4 Siegfried Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Siegfried Recent Developments and Future Plans
2.12 WuXi Biologics
2.12.1 WuXi Biologics Details
2.12.2 WuXi Biologics Major Business
2.12.3 WuXi Biologics Biological Drug CDMO Product and Solutions
2.12.4 WuXi Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 WuXi Biologics Recent Developments and Future Plans
2.13 Obio Technology
2.13.1 Obio Technology Details
2.13.2 Obio Technology Major Business
2.13.3 Obio Technology Biological Drug CDMO Product and Solutions
2.13.4 Obio Technology Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Obio Technology Recent Developments and Future Plans
2.14 Hepalink
2.14.1 Hepalink Details
2.14.2 Hepalink Major Business
2.14.3 Hepalink Biological Drug CDMO Product and Solutions
2.14.4 Hepalink Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Hepalink Recent Developments and Future Plans
2.15 Pharmaron
2.15.1 Pharmaron Details
2.15.2 Pharmaron Major Business
2.15.3 Pharmaron Biological Drug CDMO Product and Solutions
2.15.4 Pharmaron Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Pharmaron Recent Developments and Future Plans
2.16 ChemPartner
2.16.1 ChemPartner Details
2.16.2 ChemPartner Major Business
2.16.3 ChemPartner Biological Drug CDMO Product and Solutions
2.16.4 ChemPartner Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 ChemPartner Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biological Drug CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biological Drug CDMO by Company Revenue
3.2.2 Top 3 Biological Drug CDMO Players Market Share in 2022
3.2.3 Top 6 Biological Drug CDMO Players Market Share in 2022
3.3 Biological Drug CDMO Market: Overall Company Footprint Analysis
3.3.1 Biological Drug CDMO Market: Region Footprint
3.3.2 Biological Drug CDMO Market: Company Product Type Footprint
3.3.3 Biological Drug CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biological Drug CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biological Drug CDMO Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biological Drug CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Biological Drug CDMO Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biological Drug CDMO Consumption Value by Type (2018-2029)
6.2 North America Biological Drug CDMO Consumption Value by Application (2018-2029)
6.3 North America Biological Drug CDMO Market Size by Country
6.3.1 North America Biological Drug CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Biological Drug CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Biological Drug CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Biological Drug CDMO Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Biological Drug CDMO Consumption Value by Type (2018-2029)
7.2 Europe Biological Drug CDMO Consumption Value by Application (2018-2029)
7.3 Europe Biological Drug CDMO Market Size by Country
7.3.1 Europe Biological Drug CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Biological Drug CDMO Market Size and Forecast (2018-2029)
7.3.3 France Biological Drug CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biological Drug CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Biological Drug CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Biological Drug CDMO Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biological Drug CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biological Drug CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biological Drug CDMO Market Size by Region
8.3.1 Asia-Pacific Biological Drug CDMO Consumption Value by Region (2018-2029)
8.3.2 China Biological Drug CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Biological Drug CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Biological Drug CDMO Market Size and Forecast (2018-2029)
8.3.5 India Biological Drug CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biological Drug CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Biological Drug CDMO Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Biological Drug CDMO Consumption Value by Type (2018-2029)
9.2 South America Biological Drug CDMO Consumption Value by Application (2018-2029)
9.3 South America Biological Drug CDMO Market Size by Country
9.3.1 South America Biological Drug CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Biological Drug CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Biological Drug CDMO Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biological Drug CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biological Drug CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biological Drug CDMO Market Size by Country
10.3.1 Middle East & Africa Biological Drug CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Biological Drug CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biological Drug CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Biological Drug CDMO Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Biological Drug CDMO Market Drivers
11.2 Biological Drug CDMO Market Restraints
11.3 Biological Drug CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Biological Drug CDMO Industry Chain
12.2 Biological Drug CDMO Upstream Analysis
12.3 Biological Drug CDMO Midstream Analysis
12.4 Biological Drug CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Biological Drug CDMO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biological Drug CDMO by Type
1.3.1 Overview: Global Biological Drug CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biological Drug CDMO Consumption Value Market Share by Type in 2022
1.3.3 Innovative Drug
1.3.4 Listed Patent Drugs
1.3.5 Biosimilar
1.4 Global Biological Drug CDMO Market by Application
1.4.1 Overview: Global Biological Drug CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.5 Global Biological Drug CDMO Market Size & Forecast
1.6 Global Biological Drug CDMO Market Size and Forecast by Region
1.6.1 Global Biological Drug CDMO Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biological Drug CDMO Market Size by Region, (2018-2029)
1.6.3 North America Biological Drug CDMO Market Size and Prospect (2018-2029)
1.6.4 Europe Biological Drug CDMO Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biological Drug CDMO Market Size and Prospect (2018-2029)
1.6.6 South America Biological Drug CDMO Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biological Drug CDMO Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Samsung Biologics
2.1.1 Samsung Biologics Details
2.1.2 Samsung Biologics Major Business
2.1.3 Samsung Biologics Biological Drug CDMO Product and Solutions
2.1.4 Samsung Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Samsung Biologics Recent Developments and Future Plans
2.2 Lonza
2.2.1 Lonza Details
2.2.2 Lonza Major Business
2.2.3 Lonza Biological Drug CDMO Product and Solutions
2.2.4 Lonza Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Lonza Recent Developments and Future Plans
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Biological Drug CDMO Product and Solutions
2.3.4 Boehringer Ingelheim Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
2.4 Catalent
2.4.1 Catalent Details
2.4.2 Catalent Major Business
2.4.3 Catalent Biological Drug CDMO Product and Solutions
2.4.4 Catalent Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Catalent Recent Developments and Future Plans
2.5 BioCentriq
2.5.1 BioCentriq Details
2.5.2 BioCentriq Major Business
2.5.3 BioCentriq Biological Drug CDMO Product and Solutions
2.5.4 BioCentriq Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 BioCentriq Recent Developments and Future Plans
2.6 FUJIFILM Diosynth Biotechnologies
2.6.1 FUJIFILM Diosynth Biotechnologies Details
2.6.2 FUJIFILM Diosynth Biotechnologies Major Business
2.6.3 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product and Solutions
2.6.4 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.7 Thermo Fisher Scientific
2.7.1 Thermo Fisher Scientific Details
2.7.2 Thermo Fisher Scientific Major Business
2.7.3 Thermo Fisher Scientific Biological Drug CDMO Product and Solutions
2.7.4 Thermo Fisher Scientific Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.8 Recipharm
2.8.1 Recipharm Details
2.8.2 Recipharm Major Business
2.8.3 Recipharm Biological Drug CDMO Product and Solutions
2.8.4 Recipharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Recipharm Recent Developments and Future Plans
2.9 Delpharm
2.9.1 Delpharm Details
2.9.2 Delpharm Major Business
2.9.3 Delpharm Biological Drug CDMO Product and Solutions
2.9.4 Delpharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Delpharm Recent Developments and Future Plans
2.10 Aenova
2.10.1 Aenova Details
2.10.2 Aenova Major Business
2.10.3 Aenova Biological Drug CDMO Product and Solutions
2.10.4 Aenova Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Aenova Recent Developments and Future Plans
2.11 Siegfried
2.11.1 Siegfried Details
2.11.2 Siegfried Major Business
2.11.3 Siegfried Biological Drug CDMO Product and Solutions
2.11.4 Siegfried Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Siegfried Recent Developments and Future Plans
2.12 WuXi Biologics
2.12.1 WuXi Biologics Details
2.12.2 WuXi Biologics Major Business
2.12.3 WuXi Biologics Biological Drug CDMO Product and Solutions
2.12.4 WuXi Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 WuXi Biologics Recent Developments and Future Plans
2.13 Obio Technology
2.13.1 Obio Technology Details
2.13.2 Obio Technology Major Business
2.13.3 Obio Technology Biological Drug CDMO Product and Solutions
2.13.4 Obio Technology Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Obio Technology Recent Developments and Future Plans
2.14 Hepalink
2.14.1 Hepalink Details
2.14.2 Hepalink Major Business
2.14.3 Hepalink Biological Drug CDMO Product and Solutions
2.14.4 Hepalink Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Hepalink Recent Developments and Future Plans
2.15 Pharmaron
2.15.1 Pharmaron Details
2.15.2 Pharmaron Major Business
2.15.3 Pharmaron Biological Drug CDMO Product and Solutions
2.15.4 Pharmaron Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Pharmaron Recent Developments and Future Plans
2.16 ChemPartner
2.16.1 ChemPartner Details
2.16.2 ChemPartner Major Business
2.16.3 ChemPartner Biological Drug CDMO Product and Solutions
2.16.4 ChemPartner Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 ChemPartner Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biological Drug CDMO Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biological Drug CDMO by Company Revenue
3.2.2 Top 3 Biological Drug CDMO Players Market Share in 2022
3.2.3 Top 6 Biological Drug CDMO Players Market Share in 2022
3.3 Biological Drug CDMO Market: Overall Company Footprint Analysis
3.3.1 Biological Drug CDMO Market: Region Footprint
3.3.2 Biological Drug CDMO Market: Company Product Type Footprint
3.3.3 Biological Drug CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biological Drug CDMO Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biological Drug CDMO Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biological Drug CDMO Consumption Value Market Share by Application (2018-2023)
5.2 Global Biological Drug CDMO Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biological Drug CDMO Consumption Value by Type (2018-2029)
6.2 North America Biological Drug CDMO Consumption Value by Application (2018-2029)
6.3 North America Biological Drug CDMO Market Size by Country
6.3.1 North America Biological Drug CDMO Consumption Value by Country (2018-2029)
6.3.2 United States Biological Drug CDMO Market Size and Forecast (2018-2029)
6.3.3 Canada Biological Drug CDMO Market Size and Forecast (2018-2029)
6.3.4 Mexico Biological Drug CDMO Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Biological Drug CDMO Consumption Value by Type (2018-2029)
7.2 Europe Biological Drug CDMO Consumption Value by Application (2018-2029)
7.3 Europe Biological Drug CDMO Market Size by Country
7.3.1 Europe Biological Drug CDMO Consumption Value by Country (2018-2029)
7.3.2 Germany Biological Drug CDMO Market Size and Forecast (2018-2029)
7.3.3 France Biological Drug CDMO Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biological Drug CDMO Market Size and Forecast (2018-2029)
7.3.5 Russia Biological Drug CDMO Market Size and Forecast (2018-2029)
7.3.6 Italy Biological Drug CDMO Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biological Drug CDMO Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biological Drug CDMO Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biological Drug CDMO Market Size by Region
8.3.1 Asia-Pacific Biological Drug CDMO Consumption Value by Region (2018-2029)
8.3.2 China Biological Drug CDMO Market Size and Forecast (2018-2029)
8.3.3 Japan Biological Drug CDMO Market Size and Forecast (2018-2029)
8.3.4 South Korea Biological Drug CDMO Market Size and Forecast (2018-2029)
8.3.5 India Biological Drug CDMO Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biological Drug CDMO Market Size and Forecast (2018-2029)
8.3.7 Australia Biological Drug CDMO Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Biological Drug CDMO Consumption Value by Type (2018-2029)
9.2 South America Biological Drug CDMO Consumption Value by Application (2018-2029)
9.3 South America Biological Drug CDMO Market Size by Country
9.3.1 South America Biological Drug CDMO Consumption Value by Country (2018-2029)
9.3.2 Brazil Biological Drug CDMO Market Size and Forecast (2018-2029)
9.3.3 Argentina Biological Drug CDMO Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biological Drug CDMO Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biological Drug CDMO Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biological Drug CDMO Market Size by Country
10.3.1 Middle East & Africa Biological Drug CDMO Consumption Value by Country (2018-2029)
10.3.2 Turkey Biological Drug CDMO Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biological Drug CDMO Market Size and Forecast (2018-2029)
10.3.4 UAE Biological Drug CDMO Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Biological Drug CDMO Market Drivers
11.2 Biological Drug CDMO Market Restraints
11.3 Biological Drug CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Biological Drug CDMO Industry Chain
12.2 Biological Drug CDMO Upstream Analysis
12.3 Biological Drug CDMO Midstream Analysis
12.4 Biological Drug CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biological Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biological Drug CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biological Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biological Drug CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 6. Samsung Biologics Major Business
Table 7. Samsung Biologics Biological Drug CDMO Product and Solutions
Table 8. Samsung Biologics Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Samsung Biologics Recent Developments and Future Plans
Table 10. Lonza Company Information, Head Office, and Major Competitors
Table 11. Lonza Major Business
Table 12. Lonza Biological Drug CDMO Product and Solutions
Table 13. Lonza Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Lonza Recent Developments and Future Plans
Table 15. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 16. Boehringer Ingelheim Major Business
Table 17. Boehringer Ingelheim Biological Drug CDMO Product and Solutions
Table 18. Boehringer Ingelheim Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Boehringer Ingelheim Recent Developments and Future Plans
Table 20. Catalent Company Information, Head Office, and Major Competitors
Table 21. Catalent Major Business
Table 22. Catalent Biological Drug CDMO Product and Solutions
Table 23. Catalent Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Catalent Recent Developments and Future Plans
Table 25. BioCentriq Company Information, Head Office, and Major Competitors
Table 26. BioCentriq Major Business
Table 27. BioCentriq Biological Drug CDMO Product and Solutions
Table 28. BioCentriq Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. BioCentriq Recent Developments and Future Plans
Table 30. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 31. FUJIFILM Diosynth Biotechnologies Major Business
Table 32. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product and Solutions
Table 33. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 35. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Biological Drug CDMO Product and Solutions
Table 38. Thermo Fisher Scientific Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Thermo Fisher Scientific Recent Developments and Future Plans
Table 40. Recipharm Company Information, Head Office, and Major Competitors
Table 41. Recipharm Major Business
Table 42. Recipharm Biological Drug CDMO Product and Solutions
Table 43. Recipharm Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Recipharm Recent Developments and Future Plans
Table 45. Delpharm Company Information, Head Office, and Major Competitors
Table 46. Delpharm Major Business
Table 47. Delpharm Biological Drug CDMO Product and Solutions
Table 48. Delpharm Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Delpharm Recent Developments and Future Plans
Table 50. Aenova Company Information, Head Office, and Major Competitors
Table 51. Aenova Major Business
Table 52. Aenova Biological Drug CDMO Product and Solutions
Table 53. Aenova Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Aenova Recent Developments and Future Plans
Table 55. Siegfried Company Information, Head Office, and Major Competitors
Table 56. Siegfried Major Business
Table 57. Siegfried Biological Drug CDMO Product and Solutions
Table 58. Siegfried Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Siegfried Recent Developments and Future Plans
Table 60. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 61. WuXi Biologics Major Business
Table 62. WuXi Biologics Biological Drug CDMO Product and Solutions
Table 63. WuXi Biologics Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. WuXi Biologics Recent Developments and Future Plans
Table 65. Obio Technology Company Information, Head Office, and Major Competitors
Table 66. Obio Technology Major Business
Table 67. Obio Technology Biological Drug CDMO Product and Solutions
Table 68. Obio Technology Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Obio Technology Recent Developments and Future Plans
Table 70. Hepalink Company Information, Head Office, and Major Competitors
Table 71. Hepalink Major Business
Table 72. Hepalink Biological Drug CDMO Product and Solutions
Table 73. Hepalink Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Hepalink Recent Developments and Future Plans
Table 75. Pharmaron Company Information, Head Office, and Major Competitors
Table 76. Pharmaron Major Business
Table 77. Pharmaron Biological Drug CDMO Product and Solutions
Table 78. Pharmaron Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Pharmaron Recent Developments and Future Plans
Table 80. ChemPartner Company Information, Head Office, and Major Competitors
Table 81. ChemPartner Major Business
Table 82. ChemPartner Biological Drug CDMO Product and Solutions
Table 83. ChemPartner Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. ChemPartner Recent Developments and Future Plans
Table 85. Global Biological Drug CDMO Revenue (USD Million) by Players (2018-2023)
Table 86. Global Biological Drug CDMO Revenue Share by Players (2018-2023)
Table 87. Breakdown of Biological Drug CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Biological Drug CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Biological Drug CDMO Players
Table 90. Biological Drug CDMO Market: Company Product Type Footprint
Table 91. Biological Drug CDMO Market: Company Product Application Footprint
Table 92. Biological Drug CDMO New Market Entrants and Barriers to Market Entry
Table 93. Biological Drug CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Biological Drug CDMO Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Biological Drug CDMO Consumption Value Share by Type (2018-2023)
Table 96. Global Biological Drug CDMO Consumption Value Forecast by Type (2024-2029)
Table 97. Global Biological Drug CDMO Consumption Value by Application (2018-2023)
Table 98. Global Biological Drug CDMO Consumption Value Forecast by Application (2024-2029)
Table 99. North America Biological Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Biological Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Biological Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Biological Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Biological Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Biological Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Biological Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Biological Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Biological Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Biological Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Biological Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Biological Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Biological Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Biological Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Biological Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Biological Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Biological Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Biological Drug CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Biological Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Biological Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Biological Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Biological Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Biological Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Biological Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Biological Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Biological Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Biological Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Biological Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Biological Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Biological Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Biological Drug CDMO Raw Material
Table 130. Key Suppliers of Biological Drug CDMO Raw Materials
Table 1. Global Biological Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biological Drug CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biological Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biological Drug CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 6. Samsung Biologics Major Business
Table 7. Samsung Biologics Biological Drug CDMO Product and Solutions
Table 8. Samsung Biologics Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Samsung Biologics Recent Developments and Future Plans
Table 10. Lonza Company Information, Head Office, and Major Competitors
Table 11. Lonza Major Business
Table 12. Lonza Biological Drug CDMO Product and Solutions
Table 13. Lonza Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Lonza Recent Developments and Future Plans
Table 15. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 16. Boehringer Ingelheim Major Business
Table 17. Boehringer Ingelheim Biological Drug CDMO Product and Solutions
Table 18. Boehringer Ingelheim Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Boehringer Ingelheim Recent Developments and Future Plans
Table 20. Catalent Company Information, Head Office, and Major Competitors
Table 21. Catalent Major Business
Table 22. Catalent Biological Drug CDMO Product and Solutions
Table 23. Catalent Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Catalent Recent Developments and Future Plans
Table 25. BioCentriq Company Information, Head Office, and Major Competitors
Table 26. BioCentriq Major Business
Table 27. BioCentriq Biological Drug CDMO Product and Solutions
Table 28. BioCentriq Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. BioCentriq Recent Developments and Future Plans
Table 30. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 31. FUJIFILM Diosynth Biotechnologies Major Business
Table 32. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product and Solutions
Table 33. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 35. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Biological Drug CDMO Product and Solutions
Table 38. Thermo Fisher Scientific Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Thermo Fisher Scientific Recent Developments and Future Plans
Table 40. Recipharm Company Information, Head Office, and Major Competitors
Table 41. Recipharm Major Business
Table 42. Recipharm Biological Drug CDMO Product and Solutions
Table 43. Recipharm Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Recipharm Recent Developments and Future Plans
Table 45. Delpharm Company Information, Head Office, and Major Competitors
Table 46. Delpharm Major Business
Table 47. Delpharm Biological Drug CDMO Product and Solutions
Table 48. Delpharm Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Delpharm Recent Developments and Future Plans
Table 50. Aenova Company Information, Head Office, and Major Competitors
Table 51. Aenova Major Business
Table 52. Aenova Biological Drug CDMO Product and Solutions
Table 53. Aenova Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Aenova Recent Developments and Future Plans
Table 55. Siegfried Company Information, Head Office, and Major Competitors
Table 56. Siegfried Major Business
Table 57. Siegfried Biological Drug CDMO Product and Solutions
Table 58. Siegfried Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Siegfried Recent Developments and Future Plans
Table 60. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 61. WuXi Biologics Major Business
Table 62. WuXi Biologics Biological Drug CDMO Product and Solutions
Table 63. WuXi Biologics Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. WuXi Biologics Recent Developments and Future Plans
Table 65. Obio Technology Company Information, Head Office, and Major Competitors
Table 66. Obio Technology Major Business
Table 67. Obio Technology Biological Drug CDMO Product and Solutions
Table 68. Obio Technology Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Obio Technology Recent Developments and Future Plans
Table 70. Hepalink Company Information, Head Office, and Major Competitors
Table 71. Hepalink Major Business
Table 72. Hepalink Biological Drug CDMO Product and Solutions
Table 73. Hepalink Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Hepalink Recent Developments and Future Plans
Table 75. Pharmaron Company Information, Head Office, and Major Competitors
Table 76. Pharmaron Major Business
Table 77. Pharmaron Biological Drug CDMO Product and Solutions
Table 78. Pharmaron Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Pharmaron Recent Developments and Future Plans
Table 80. ChemPartner Company Information, Head Office, and Major Competitors
Table 81. ChemPartner Major Business
Table 82. ChemPartner Biological Drug CDMO Product and Solutions
Table 83. ChemPartner Biological Drug CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. ChemPartner Recent Developments and Future Plans
Table 85. Global Biological Drug CDMO Revenue (USD Million) by Players (2018-2023)
Table 86. Global Biological Drug CDMO Revenue Share by Players (2018-2023)
Table 87. Breakdown of Biological Drug CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Biological Drug CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Biological Drug CDMO Players
Table 90. Biological Drug CDMO Market: Company Product Type Footprint
Table 91. Biological Drug CDMO Market: Company Product Application Footprint
Table 92. Biological Drug CDMO New Market Entrants and Barriers to Market Entry
Table 93. Biological Drug CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Biological Drug CDMO Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Biological Drug CDMO Consumption Value Share by Type (2018-2023)
Table 96. Global Biological Drug CDMO Consumption Value Forecast by Type (2024-2029)
Table 97. Global Biological Drug CDMO Consumption Value by Application (2018-2023)
Table 98. Global Biological Drug CDMO Consumption Value Forecast by Application (2024-2029)
Table 99. North America Biological Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Biological Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Biological Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Biological Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Biological Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Biological Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Biological Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Biological Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Biological Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Biological Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Biological Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Biological Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Biological Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Biological Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Biological Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Biological Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Biological Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Biological Drug CDMO Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Biological Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Biological Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Biological Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Biological Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Biological Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Biological Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Biological Drug CDMO Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Biological Drug CDMO Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Biological Drug CDMO Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Biological Drug CDMO Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Biological Drug CDMO Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Biological Drug CDMO Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Biological Drug CDMO Raw Material
Table 130. Key Suppliers of Biological Drug CDMO Raw Materials
LIST OF FIGURES
Figure 1. Biological Drug CDMO Picture
Figure 2. Global Biological Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biological Drug CDMO Consumption Value Market Share by Type in 2022
Figure 4. Innovative Drug
Figure 5. Listed Patent Drugs
Figure 6. Biosimilar
Figure 7. Global Biological Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Biological Drug CDMO Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical Company Picture
Figure 10. Biotechnology Company Picture
Figure 11. Global Biological Drug CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Biological Drug CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Biological Drug CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Biological Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Biological Drug CDMO Consumption Value Market Share by Region in 2022
Figure 16. North America Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Biological Drug CDMO Revenue Share by Players in 2022
Figure 22. Biological Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Biological Drug CDMO Market Share in 2022
Figure 24. Global Top 6 Players Biological Drug CDMO Market Share in 2022
Figure 25. Global Biological Drug CDMO Consumption Value Share by Type (2018-2023)
Figure 26. Global Biological Drug CDMO Market Share Forecast by Type (2024-2029)
Figure 27. Global Biological Drug CDMO Consumption Value Share by Application (2018-2023)
Figure 28. Global Biological Drug CDMO Market Share Forecast by Application (2024-2029)
Figure 29. North America Biological Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Biological Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Biological Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Biological Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Biological Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Biological Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 39. France Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Biological Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Biological Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Biological Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 46. China Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 49. India Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Biological Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Biological Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Biological Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Biological Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Biological Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Biological Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 63. Biological Drug CDMO Market Drivers
Figure 64. Biological Drug CDMO Market Restraints
Figure 65. Biological Drug CDMO Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Biological Drug CDMO in 2022
Figure 68. Manufacturing Process Analysis of Biological Drug CDMO
Figure 69. Biological Drug CDMO Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Biological Drug CDMO Picture
Figure 2. Global Biological Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biological Drug CDMO Consumption Value Market Share by Type in 2022
Figure 4. Innovative Drug
Figure 5. Listed Patent Drugs
Figure 6. Biosimilar
Figure 7. Global Biological Drug CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Biological Drug CDMO Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical Company Picture
Figure 10. Biotechnology Company Picture
Figure 11. Global Biological Drug CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Biological Drug CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Biological Drug CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Biological Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Biological Drug CDMO Consumption Value Market Share by Region in 2022
Figure 16. North America Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Biological Drug CDMO Revenue Share by Players in 2022
Figure 22. Biological Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Biological Drug CDMO Market Share in 2022
Figure 24. Global Top 6 Players Biological Drug CDMO Market Share in 2022
Figure 25. Global Biological Drug CDMO Consumption Value Share by Type (2018-2023)
Figure 26. Global Biological Drug CDMO Market Share Forecast by Type (2024-2029)
Figure 27. Global Biological Drug CDMO Consumption Value Share by Application (2018-2023)
Figure 28. Global Biological Drug CDMO Market Share Forecast by Application (2024-2029)
Figure 29. North America Biological Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Biological Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Biological Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Biological Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Biological Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Biological Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 39. France Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Biological Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Biological Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Biological Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 46. China Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 49. India Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Biological Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Biological Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Biological Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Biological Drug CDMO Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Biological Drug CDMO Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Biological Drug CDMO Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 63. Biological Drug CDMO Market Drivers
Figure 64. Biological Drug CDMO Market Restraints
Figure 65. Biological Drug CDMO Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Biological Drug CDMO in 2022
Figure 68. Manufacturing Process Analysis of Biological Drug CDMO
Figure 69. Biological Drug CDMO Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
